Clear Harbor Asset Management LLC boosted its stake in shares of Laboratory Corp. of America Holdings (NYSE:LH) by 21.4% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,948 shares of the medical research company’s stock after buying an additional 343 shares during the quarter. Clear Harbor Asset Management LLC’s holdings in Laboratory Corp. of America were worth $298,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Shine Investment Advisory Services Inc. raised its position in shares of Laboratory Corp. of America by 30.7% in the 1st quarter. Shine Investment Advisory Services Inc. now owns 277 shares of the medical research company’s stock worth $42,000 after acquiring an additional 65 shares in the last quarter. Thrivent Financial for Lutherans raised its position in shares of Laboratory Corp. of America by 1.8% in the 4th quarter. Thrivent Financial for Lutherans now owns 4,471 shares of the medical research company’s stock worth $565,000 after acquiring an additional 78 shares in the last quarter. Bailard Inc. raised its position in shares of Laboratory Corp. of America by 5.2% in the 4th quarter. Bailard Inc. now owns 1,825 shares of the medical research company’s stock worth $231,000 after acquiring an additional 90 shares in the last quarter. White Pine Investment CO raised its position in shares of Laboratory Corp. of America by 0.4% in the 4th quarter. White Pine Investment CO now owns 24,878 shares of the medical research company’s stock worth $3,144,000 after acquiring an additional 90 shares in the last quarter. Finally, Leavell Investment Management Inc. raised its position in shares of Laboratory Corp. of America by 1.8% in the 1st quarter. Leavell Investment Management Inc. now owns 5,533 shares of the medical research company’s stock worth $846,000 after acquiring an additional 100 shares in the last quarter. 91.51% of the stock is currently owned by hedge funds and other institutional investors.

Shares of Laboratory Corp. of America stock opened at $145.22 on Friday. Laboratory Corp. of America Holdings has a one year low of $119.38 and a one year high of $190.35. The stock has a market capitalization of $14.33 billion, a P/E ratio of 13.18, a PEG ratio of 1.80 and a beta of 1.15. The company has a debt-to-equity ratio of 0.87, a current ratio of 1.51 and a quick ratio of 1.38.

Laboratory Corp. of America (NYSE:LH) last issued its earnings results on Thursday, February 7th. The medical research company reported $2.52 EPS for the quarter, beating analysts’ consensus estimates of $2.48 by $0.04. Laboratory Corp. of America had a return on equity of 17.05% and a net margin of 8.43%. The business had revenue of $2.79 billion during the quarter, compared to analyst estimates of $2.78 billion. During the same period in the previous year, the company posted $2.45 EPS. The firm’s revenue was up 1.6% compared to the same quarter last year. Analysts expect that Laboratory Corp. of America Holdings will post 11.22 EPS for the current fiscal year.

Several research firms have recently weighed in on LH. ValuEngine lowered Laboratory Corp. of America from a “hold” rating to a “sell” rating in a research report on Thursday. Zacks Investment Research lowered Laboratory Corp. of America from a “hold” rating to a “sell” rating in a research report on Tuesday, January 8th. Jefferies Financial Group raised Laboratory Corp. of America from a “hold” rating to a “buy” rating and lifted their price objective for the stock from $154.00 to $190.00 in a research report on Tuesday, April 2nd. Barclays lifted their price objective on Laboratory Corp. of America from $165.00 to $173.00 and gave the stock an “overweight” rating in a research report on Monday, March 18th. Finally, TheStreet lowered Laboratory Corp. of America from a “b-” rating to a “c+” rating in a research report on Friday, January 11th. Three investment analysts have rated the stock with a sell rating, seven have given a hold rating and ten have assigned a buy rating to the stock. Laboratory Corp. of America presently has an average rating of “Hold” and an average price target of $175.50.

In other Laboratory Corp. of America news, Director R Sanders Williams sold 1,038 shares of the business’s stock in a transaction that occurred on Wednesday, February 13th. The stock was sold at an average price of $147.00, for a total transaction of $152,586.00. Following the completion of the sale, the director now directly owns 8,924 shares of the company’s stock, valued at approximately $1,311,828. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 0.74% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This piece of content was published by TheOlympiaReport and is the property of of TheOlympiaReport. If you are reading this piece of content on another publication, it was illegally stolen and republished in violation of United States and international copyright law. The correct version of this piece of content can be read at https://theolympiareport.com/2019/04/20/clear-harbor-asset-management-llc-buys-343-shares-of-laboratory-corp-of-america-holdings-lh.html.

About Laboratory Corp. of America

Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. It operates in two segments, LabCorp Diagnostics (LCD) and Covance Drug Development. It offers various clinical laboratory tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, hemoglobin A1C and vitamin D products, prostate-specific antigens, tests for sexually-transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests.

See Also: Understanding debt-to-equity ratio in fundamental analysis

Want to see what other hedge funds are holding LH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Laboratory Corp. of America Holdings (NYSE:LH).

Institutional Ownership by Quarter for Laboratory Corp. of America (NYSE:LH)

Receive News & Ratings for Laboratory Corp. of America Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Laboratory Corp. of America and related companies with MarketBeat.com's FREE daily email newsletter.